Equity Overview
Price & Market Data
Price: $0.585
Daily Change: $0.00 / 0.00%
Daily Range: $0.507 - $0.62
Market Cap: $9,210,191
Daily Volume: 171,849
Performance Metrics
1 Week: 0.43%
1 Month: -6.25%
3 Months: -91.12%
6 Months: -80.88%
1 Year: -68.38%
YTD: -91.12%
Company Details
Employees: 16
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.